Published in Vaccine Weekly, June 14th, 1999
The new vaccine is the first to be made from a bacterial molecule produced primarily during infection, rather than in laboratory culture.
A report of the study by scientists at Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts, appeared in the May 28, 1999, issue of Science.
"This is an intriguing finding and a hopeful step against a very worrisome pathogen," said NIAID Director Anthony S. Fauci, MD. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.